The Society for Maternal-Fetal Medicine (SMFM) 43rd Annual Pregnancy Meeting

San Francisco, California 06 February 2023 - 11 February 2023

Intermittent outdoes continuous catheterization for postpartum urinary retention

27 Feb 2023 by

In women with postpartum urinary retention (PUR; bladder volume ≥150 mL) up to 6 hours following vaginal or Caesarean delivery, intermittent catheterization led to quicker time to PUR resolution and was associated with a higher satisfaction rate than continuous catheterization, with no additional complications, a study from Israel reports.

Intermittent outdoes continuous catheterization for postpartum urinary retention

27 Feb 2023

Tighter BP control improves pregnancy outcomes in women with DM, chronic hypertension

23 Feb 2023 by

Further lowering blood pressure helps cut the risk of adverse perinatal events for pregnant women with pregestational diabetes mellitus (DM) and mild chronic hypertension, according to the secondary analysis of the Chronic Hypertension and Adverse Pregnancy (CHAP) study presented at SMFM 2023.

Tighter BP control improves pregnancy outcomes in women with DM, chronic hypertension

23 Feb 2023

Increased ketorolac doses reduce opioid use following caesarean delivery

23 Feb 2023 by

In women undergoing caesarean section (C-section), six scheduled doses of ketorolac reduced postoperative opioid use as opposed to having only two doses.

Increased ketorolac doses reduce opioid use following caesarean delivery

23 Feb 2023

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

23 Feb 2023 by

Treatment with either labetalol or nifedipine is similarly effective in reducing adverse maternal outcomes among women with mild chronic hypertension (CHTN) in pregnancy, according to a study presented at SMFM 2023.

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

23 Feb 2023

Cannabis use among expectant mums compromises pregnancy

22 Feb 2023 by

Pregnant women may do well to avoid cannabis, with cannabis use in early pregnancy leading to adverse pregnancy outcomes, as reported in a study presented at Society for Maternal-Fetal Medicine (SMFM) 43rd Annual Pregnancy Meeting.

Cannabis use among expectant mums compromises pregnancy

22 Feb 2023

Which ART delivers better HIV viral suppression in pregnant women?

22 Feb 2023 by

Pregnant women living with HIV are more likely to achieve viral suppression when treated with dual-nucleoside reverse transcriptase inhibitors (NRTI) in combination with integrase (INSTI) inhibitors compared to protease (PI) inhibitors at delivery, suggests a recent study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).

Which ART delivers better HIV viral suppression in pregnant women?

22 Feb 2023

Can oxytocin be discontinued during active labour?

22 Feb 2023 by

Discontinuing oxytocin during the active stage of labour appears safe, according to the STOPOXY trial presented at SMFM 2023.

Can oxytocin be discontinued during active labour?

22 Feb 2023

Hypertensive disorders of pregnancy tied to fatty, salty diet

21 Feb 2023 by

Women who adhere to a diet rich in sodium, dairy, and saturated fats are at increased risk of hypertensive disorders of pregnancy (HDP), according to a study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).

Hypertensive disorders of pregnancy tied to fatty, salty diet

21 Feb 2023

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

17 Feb 2023 by

Uncontrolled postpartum haemorrhage (PPH) is a life-threatening complication of childbirth that is temporarily managed with uterine balloon tamponade. At SMFM 2023, researchers from the US presented findings for a new device that could control PPH safely and effectively in just 5 minutes.

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

17 Feb 2023

Single-dose azithromycin during labour prevents maternal death, sepsis

15 Feb 2023 by

Treatment with a single oral dose of azithromycin, given to women in labour who were planning a vaginal birth, significantly reduced the risk of maternal death or sepsis, according to the A-PLUS* trial presented at SMFM 2023.

Single-dose azithromycin during labour prevents maternal death, sepsis

15 Feb 2023